AXIOS October 31, 2024
The Biden administration this week is hosting a first-of-its-kind international summit about the use of artificial intelligence in the life sciences as governments and private industry increasingly push the boundaries of biotechnology.
Why it matters: The convergence of the life sciences and advanced AI could reveal the underpinnings of diseases, help identify new cures or produce more resistant crops. But there are barriers and bottlenecks — and potential risks — to combining the technologies.
The catch: Training today’s advanced AI models requires massive amounts of high-quality, standardized scientific data. But there aren’t many accessible databases with that information.
Officials hope the AI-Bioscience Collaborative (AIBC) Summit being held Thursday and Friday in Washington, D.C., can begin unlocking troves of data that...
Today's Sponsors
Today's Sponsor